• Accelerated obesity intervention in the UAE could benefit more than 1.2 million people, unlock $1.5 billion in healthcare savings, and boost GDP growth by 1.5 percentage points by 2031, positioning obesity intervention as a critical policy and economic priority,according to a new report by Whiteshield, commissioned by Eli Lilly (Suisse) S.A.  (Lilly).
• The report explores far-reaching positive impacts across the UAE’s health, economy, society, and education, demonstrating how coordinated, cross-sector obesity strategies candrive long-term transformation in line with the ‘We the UAE 2031’ vision.

Dubai, United Arab Emirates, 20May 2026 – A UAE report by AI economics policy advisory Whiteshield, commissioned by leading medicine company, Lilly, has revealed far-reaching benefits of obesity intervention across health, the economy, society, and education, in line with the ‘We the UAE 2031’ vision.